Spinal injury sufferer raises money for hospitalRSS Feed

A father of two paralysed from the chest down due to a spinal cord injury took part in cross country run in his wheelchair at the weekend to raise money for the hospital that saved his life.

Andrew Farrow, 44, who lives in Devizes, suffered a spinal cord injury when he fell from a tree in his sister's garden near Salisbury in July 2006, thisisWiltshire.co.uk reported.

He spent 14 months in the spinal unit at Salisbury District Hospital and his injuries meant he was unable to continue running the toy shop he had owned for nearly three years.

According to the website Mr Farrow became a governor of Salisbury District Hospital earlier this year and wants to raise as much money as he can to buy equipment for the hospital as part of its Stars Appeal.

"I'm generally pretty upbeat about being paralysed. I think about what I can do. I can do most stuff, I can drive, cycle, swim and be an active father and partner." Mr Farrow told the website.

According to the National Institutes of Health a spinal cord injury usually begins with a sudden, traumatic blow to the spine that fractures or dislocates vertebrae. The damage begins at the moment of injury when displaced bone fragments, disc material, or ligaments bruise or tear into spinal cord tissue.

Serious law, leading spinal cord injury solicitors.

England rugby player recovers from spinal injury to play again

04 November 2009

Rugby player Steve Thompson, who suffered spinal injury over two years ago, is to be reunited with Jonny Wilkinson today for the first time since the 2003 World Cup.Thompson suffered spinal injury in January...

Read More...

New hope for spinal injury sufferers

03 November 2009

Researchers have developed an improved version of an enzyme that degrades the dense scar tissue formed after spinal injury.By digesting the tissue that blocks re-growth of damaged nerves, the improved...

Read More...

Clinical trial of spinal cord injury treatment to continue

02 November 2009

Geron Corporation has announced that it has been given clearance by the Food and Drug Administration to continue the world's first human clinical trial of a hESC-based therapy: GRNOPC1 for acute spinal...

Read More...